Precedence Research
The global clinical trials support software solutions market size was valued at USD 12.99 billion in 2025 and is predicted to hit around USD 34.15 billion by 2035, rising at a 10.15% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research.
Ottawa, Feb. 18, 2026 (GLOBE NEWSWIRE) — The global clinical trials support software solutions market size is calculated at USD 14.31 billion in 2026 and is expected to reach around USD 34.15 billion by 2035, growing at a CAGR of 10.15% for the forecasted period.
Get a personalized preview of where clinical trial technology is heading | Download Now @ https://www.towardshealthcare.com/download-sample/6487
Key Takeaways
North America accounted for the largest share of the clinical trials support software solutions market in 2025.
Asia Pacific is expected to grow at the fastest CAGR in the studied years.
By product, the CTMS segment registered dominance in the market in 2025.
By product, the payments/investigator payment solutions segment is expected to grow at the fastest CAGR in the studied years.
By delivery mode, the cloud and web-based segment led the market in 2025.
By delivery mode, the on-premise segment is expected to grow at a significant rate in the studied years.
By phase, the phase III segment dominated the global market.
By phase, the phase I segment is expected to grow at the fastest CAGR in the studied years.
By end-use, the CROs segment led the market in 2025.
By end-use, the biopharmaceutical companies segment is expected to grow at the fastest CAGR in the studied years.
What are Clinical Trials Support Software Solutions?
Clinical trial support solutions are digital platforms that streamline trial planning, patient recruitment data management, monitoring, and regulatory compliance to improve efficiency, accuracy, and outcomes across clinical research studies. The clinical trials support software solutions market is growing due to the increasing complexity of clinical studies and the rising demand for faster, more efficient trial execution. Widespread adoption of digital tools for patient recruitment, data management, and remote monitoring improves accuracy and compliance. Additionally, growing use of decentralized and hybrid trials, regulatory pressure for data transparency, and investments in life sciences research are accelerating market growth.
For Instance,
In May 2025, the World Health Organization launched a global action plan aimed at strengthening clinical trial ecosystems worldwide. The initiative emphasizes wider use of digital technologies, improved transparency in trial registration and data sharing, and closer integration of clinical trials within national healthcare systems to enhance efficiency and research impact.